ivermectin plus doxycycline for COVID-19 - living meta-analysis of clinical studies

meta|evidence COVID-19

Living systematic review and meta-analysis

All
COVID 19 hospitalized
COVID 19 all comers
COVID-19 mild to moderate
COVID-19 severe or critically
COVID 19 outpatients
COVID-19 (hospitalized or not)
COVID-19 prophylaxis (children)
COVID-19 prophylaxis (excluding children)
infections other than COVID-19
Long COVID-19
preventing respiratory virus transmission
root
secondary prevention

Studies
Mapping
Meta-analysis
Excluded 1

table network network 2

display ongoing demontrated benefit only

click on circles to display study description...

NCT04523831 (Mahmud), 2020 NCT04523831

ivermectin plus doxycycline (n=200) vs. standard of care (n=200)

randomized controlled trial

Studied treatment

Ivermectin and Doxycycline
Ivermectin 6 mg, 2 tab stat and Doxycycline 100 mg twice daily for 5 days

Control treatment

standard of care

Patients

COVID-19 mild to moderate

Method

double blind

1 center, Bangladesh

Remark

powered by vis.js Network

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -

Extraction panel open

An extraction panel is open